Interestingly, we observed that high EHMT2 expression predicted poor prognosis outcomes for patients with HCC both in OS (hazard ratio, HR = 1.9, p = 0.00057) and DFS (HR = 1.5, p = 0.0076) analysis (Fig. 1D). This evidence concerns the gene EHMT2 and hepatocellular carcinoma.